Page last updated: 2024-08-25

zoledronic acid and Multiple Primary Neoplasms

zoledronic acid has been researched along with Multiple Primary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrillo, A; Corsi, A; Riminucci, M; Ungari, C1
Beckmann, MW; Gnant, M; Jonat, W; Kreienberg, R; Lux, MP; Reichelt, C; Thiel, FC; Wallwiener, D1

Other Studies

2 other study(ies) available for zoledronic acid and Multiple Primary Neoplasms

ArticleYear
Bisphosphonate-Related Osteonecrosis and Metastasis Within the Same Site of the Jaw.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2017, Volume: 75, Issue:8

    Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Diphosphonates; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Mandible; Mandibular Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Radiography, Panoramic; Tomography, X-Ray Computed; Zoledronic Acid

2017
Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study.
    Onkologie, 2010, Volume: 33, Issue:7

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Cost-Benefit Analysis; Diphosphonates; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Goserelin; Humans; Imidazoles; Markov Chains; Monte Carlo Method; Multicenter Studies as Topic; National Health Programs; Neoplasms, Multiple Primary; Nitriles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles; Zoledronic Acid

2010